Skip to content

AnaptysBio

US · ANAB #3010 by market cap Listed 2017
46.63 -0.77 -1.62%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 7 analysts

Buy
Avg price target 80.00 +71.6%
Price target rangecurrent 46.63
Low60.00
Avg80.00
High95.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 Piper Sandler -- Buy 93.00
2026-11-13 H.C. Wainwright -- Buy 95.00
2026-11-13 Barclays -- Buy 75.00
2026-10-26 H.C. Wainwright -- Buy 95.00
2026-10-21 Leerink Partners -- Buy 81.00
2026-10-19 H.C. Wainwright -- Buy 95.00
2026-10-05 H.C. Wainwright -- Buy 95.00
2026-09-30 J.P. Morgan -- Buy 60.00
2026-09-23 Leerink Partners -- Buy 81.00
2026-09-22 UBS -- Buy 76.00
2026-09-22 H.C. Wainwright -- Buy 95.00
2026-09-22 Barclays -- Buy 75.00
2026-09-18 Leerink Partners -- Buy --
2026-09-18 Barclays -- Buy 75.00
2026-08-25 TD Cowen -- Buy --
2026-08-24 TD Cowen -- Buy 70.00
2026-08-24 H.C. Wainwright -- Buy 95.00
2026-08-12 H.C. Wainwright -- Buy 95.00
2026-07-31 Barclays -- Buy 75.00
2026-07-23 Barclays -- Buy 75.00
2026-07-21 Piper Sandler -- Buy 93.00
2026-07-21 H.C. Wainwright -- Buy 95.00
2026-07-14 Barclays -- Buy 75.00
2026-07-13 TD Cowen -- Buy 75.00
2026-07-13 H.C. Wainwright -- Buy 95.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

AnaptysBio discussion 0 comments

Add a comment